Hudson Institute strives to improve human health through groundbreaking, collaborative, medical research discoveries and the translation of these to real world impact.
[1] The current director and CEO is distinguished researcher and international authority on microbiology and immunology, Professor Elizabeth Hartland.
[3] The Institute's purpose is stated as ‘unravelling the mysteries of nature to cure disease’.
[13] Professor Hudson was one of Australia's leading endocrinologists, and a renowned physician-scientist responsible for early work on the male reproductive hormone, Inhibin.
[16] The Institute's scientists and students have access to the MHTP Technology Platforms, which contain the following capabilities:[17]